Literature DB >> 21346604

CYP 2D6 PM status and antidepressant response to nortriptyline and venlafaxine: is it more than just drug metabolism?

Matthew Macaluso, Sheldon H Preskorn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21346604     DOI: 10.1097/JCP.0b013e318212d7cb

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  2 in total

Review 1.  PharmGKB summary: venlafaxine pathway.

Authors:  Katrin Sangkuhl; Julia C Stingl; Miia Turpeinen; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-01       Impact factor: 2.089

2.  The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes.

Authors:  Fen Jiang; Hae-Deun Kim; Han-Sung Na; Seok-Yong Lee; Doo-Won Seo; Jong-Yeol Choi; Ji-Hye Ha; Hee-Jung Shin; Young-Hoon Kim; Myeon-Woo Chung
Journal:  Psychopharmacology (Berl)       Date:  2014-12-17       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.